Ronald Shane Greene, Pharm.D., BCPS, CDE
Reportable Conflicts of Interests: None
Disclosure of Financial Conflicts of Interest: None
Education:
Doctor of Pharmacy
University of Texas at Austin in Cooperation with the University of Texas Health Science Center at San Antonio
Austin/San Antonio, TX
Post Graduate or Residency Training:
Primary Care Pharmacy Residency (ASHP Accredited)
Frank Tejeda Outpatient Clinic-South Texas Veterans Health Care System
University of Texas at Austin
University of Texas Health Science Center at San Antonio
Pharmacy Practice Residency (ASHP Accredited)
Cleveland Clinic Foundation
Cleveland, OH
Fellowship and Board Certifications:
Certified Diabetes Educator
Board Certified Pharmacotherapy Specialist
New Mexico State University’s WebCT Certification Program
Current Position or Practice Site:
Assistant Professor of Pharmacy Practice
Texas Tech University Health Sciences Center (TTUHSC)
School of Pharmacy
Dallas, TX
Adjunct Professor
Texas Woman’s University
Graduate School of Nursing
Dallas, TX
Past Positions and/or Appointments:
Assistant Professor of Pharmacy Practice August 2001-August 2008
Texas Tech University Health Sciences Center (TTUHSC)
School of Pharmacy
Dallas, TX
Retail Pharmacist (Part-time) August 2000-July 2001
Walgreen’s Pharmacy
San Antonio, TX
Staff Pharmacist (16 hours per month) July 1999-June 2000
Cleveland Clinic Foundation
Cleveland, OH
Adjunct Assistant Professor, Department of Internal Medicine September 2004
University of North Texas Health Science Center at Fort Worth
Fort Worth, TX
Clinical Instructor August 2000-July 2001
University of Texas College of Pharmacy
University of Texas Health Science at San Antonio
San Antonio, TX
Professional Memberships:
American College of Clinical Pharmacy
Dallas/Fort Worth Chapter of the American College of Clinical Pharmacy
Texas Society of Health-Systems Pharmacists
National Lipid Association
Kappa Psi Pharmaceutical Fraternity
Phi Lambda Sigma
Publications:
Alvarez CA, Russell NM, Edwards KL, Greene RS, Chastain LM, Weideman RA, Busti AJ. Combination thiazolidinedione and fibrate effect on high-density lipoprotein cholesterol (HDL-C) concentration in a Veterans Affairs patient population. J Clin Lipidol 2008;2:447-52.
Greene RS, Quinones ME, Edwards KE. Evaluation of thiazide diuretic use as preferred therapy in uncomplicated essential hypertension patients. Pharmacy Practice. Pharmacy Practice 2007;5(3):130-134.
Shah S, Dowell J, Greene RS. Evaluation of clinical pharmacy services in a hematology/oncology outpatient setting. Ann Pharmacother. 2006;40:1527-32.
Snella KA, Canales AE, Irons BK, Sleeper-Irons RB, Villarreal MC, Levi-Derrick VE, Greene RS, Jolly JL, Nelson AA. Pharmacy and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals. J Am Pharm Assoc. 2006;46(3):370-7.
Greene RS, Abshire A, Donley J, Khurana IP. Nicardipine-induced erythema nodosum. Texas Society of Health-System Pharmacists Journal 2007;8(3):23-5.
Irons BK, Greene RS, Mazzolini TA, Edwards KL, Sleeper RB. Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus. Pharmacotherapy. 2006;26(2):168-81.
Irons BK, Mazzolini TA, Greene RS. Delaying the onset of type 2 diabetes mellitus in patients with prediabetes. Pharmacotherapy 2004;24(3):362-71.
(Last updated: 2/9/2009)
